The present invention concerns regulation of complement activation, in particular the fluid phase regulation of complement activation, and provides molecules comprising at least complement control protein modules 1-4 of complement factor H, DNA molecules encoding same, their use in the manufacture of a medicament for inhibiting complement activation and methods of same, together with DNA sequences encoding rat FH 4.3 and 1.0 kb mRNA.

 
Web www.patentalert.com

< Oxidized reversibly swelling granular starch products

< Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained

> Purification of pure disaccharide solution

> Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof
~ 00281